Forte Biosciences, Inc.
FBRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $22,244 | $11,961 | $41,100 | $42,044 |
| Short-Term Investments | $36,121 | $25,164 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2,981 | $1,202 | $411 | $476 |
| Total Curr. Assets | $61,346 | $38,327 | $41,511 | $42,520 |
| Property Plant & Equip (Net) | $77 | $109 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $138 | $544 | $486 | $786 |
| Total NC Assets | $215 | $653 | $486 | $786 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $61,561 | $38,980 | $41,997 | $43,306 |
| Liabilities | – | – | – | – |
| Payables | $4,879 | $1,424 | $1,153 | $946 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $4,202 | $2,242 | $2,026 | $812 |
| Total Curr. Liab. | $9,081 | $3,666 | $3,179 | $1,758 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $9,081 | $3,666 | $3,179 | $1,758 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $43,306 |
| Common Stock | $6 | $36 | $21 | $15 |
| Retained Earnings | -$153,998 | -$118,520 | -$87,044 | -$73,165 |
| AOCI | $11 | $4 | $0 | -$43,306 |
| Other Equity | $206,461 | $153,794 | $125,841 | $114,698 |
| Total Equity | $52,480 | $35,314 | $38,818 | $41,548 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $61,561 | $38,980 | $41,997 | $43,306 |
| Net Debt | -$22,244 | -$11,961 | -$41,100 | -$42,044 |